Patents by Inventor Robert C. Baxter

Robert C. Baxter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5902026
    Abstract: An enclosure (10) includes a door (12) having a window panel (20) extending from a top edge to a bottom edge. The door (12) includes venting members (26) having vents formed therein extending substantially along either lateral edge of the window panel (20). A spaced apart inner portion (60) provides a vertical conduit for improved circulation. The window panel (20) attaches with adhesive (50) on engagement surfaces (32, 34 and 36) as well as a mechanical connection through threaded members (44).
    Type: Grant
    Filed: February 3, 1997
    Date of Patent: May 11, 1999
    Assignee: Hoffman Enclosures, Inc.
    Inventors: David A. Swan, Todd J. Mickley, Robert C. Baxter
  • Patent number: 5561046
    Abstract: An acid-labile protein is described that, when incubated with the 53-Kd acid-stable protein occupied by IGF, converts it to a high molecular weight complex, corresponding to the in vivo form of IGF. This protein is called the acid-labile subunit (ALS) of IGF binding protein complex and is provided in biologically pure form. ALS is useful in treating wounds and promoting cellular growth. The nucleic acid encoding ALS, antibodies binding thereto, and fragments thereof are also disclosed.
    Type: Grant
    Filed: March 14, 1994
    Date of Patent: October 1, 1996
    Assignee: Genentech, Inc.
    Inventor: Robert C. Baxter
  • Patent number: 5328891
    Abstract: DNA isolates coding for insulin-like growth factor binding protein may be used to produce the protein via recombinant expression systems. Insulin-like growth factor binding protein, which generally has a molecular weight of about 53 kD on non-reducing SDS-PAGE, is useful as a binder to insulin-like growth factor and as a metabolic regulator.
    Type: Grant
    Filed: January 13, 1993
    Date of Patent: July 12, 1994
    Assignees: Genentech, Inc., Central Sydney Area Health Service
    Inventors: Robert C. Baxter, William I. Wood
  • Patent number: 5324820
    Abstract: An acid-labile protein is described that, when incubated with the 53-Kd acid-stable protein occupied by IGF, converts it to a high molecular weight complex, corresponding to the in vivo form of IGF. This protein is called the acid-labile subunit (ALS) of IGF binding protein complex and is provided in biologically pure form. ALS is useful in treating wounds and promoting cellular growth.
    Type: Grant
    Filed: December 11, 1992
    Date of Patent: June 28, 1994
    Assignee: Central Sydney Area Health Service
    Inventor: Robert C. Baxter
  • Patent number: 5258287
    Abstract: DNA isolates coding for insulin-like growth factor binding protein may be used to produce the protein via recombinant expression systems. Insulin-like growth factor binding protein, which generally has a molecular weight of about 53 kD on non-reducing SDS-PAGE, is useful as a binder to insulin-like growth factor and as a metabolic regulator.
    Type: Grant
    Filed: March 22, 1988
    Date of Patent: November 2, 1993
    Assignees: Genentech, Inc., Central Sydney Area Health Service
    Inventors: Robert C. Baxter, William I. Wood
  • Patent number: D402639
    Type: Grant
    Filed: February 3, 1997
    Date of Patent: December 15, 1998
    Assignee: Hoffman Enclosures, Inc.
    Inventors: Robert C. Baxter, David A. Swan, Todd J. Mickley